AERI - Aerie Pharmaceuticals Stock Trading

Aerie Pharmaceuticals Inc.(NASDAQ: AERI) stock trading, description, contact, officers and directors.

About Aerie Pharmaceuticals Inc.

Not available

Stock Information

Aerie Pharmaceuticals Inc. Company Name:

AERI Stock Symbol:

NASDAQ Market:

Get AERI Alerts

News, Short Squeeze, Breakout and More Instantly...

NEXT ALERT COUNTDOWN

RECENT AERI NEWS

AERI - FDA approves Aerie Pharma's Ireland facility

The FDA has approved Aerie Pharmaceuticals' (NASDAQ: AERI ) sterile fill production facility in Athlone, Ireland to produce Rocklatan (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% for the U.S. market. More news on: Aerie Pharmaceuticals, Inc., Healthcare stocks ...
AERI - Aerie Pharmaceuticals Announces U.S. Food and Drug Administration Approval of its Athlone, Ireland Facility for Production of Rocklatan® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, dry eye, retinal diseases and other diseases of the eye today announc...
AERI - Oyster Point Pharma up 5% on positive data on lead candidate

Oyster Point Pharma ( OYST +4.6% ) is up on average volume in response to positive topline results from a Phase 2 clinical trial, MYSTIC , evaluating lead candidate OC-01 nasal spray for the treatment of dry eye disease. More news on: Oyster Point Pharma, Inc., Kala Pharmaceuticals,...